effects of azacitidine on MDS outcome
Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR) / Pierre Fenaux, Ghulam J Mufti, Eva Hellström-Lindberg, Valeria Santini, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F Seymour, Jay Backstrom, Linda Zimmerman, David McKenzie, C. L. Beach, and Lewis B. Silverman. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 112:(2008), pp. 3636-3636. (American society of hematology ).
Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR)
SANTINI, VALERIA;
2008
Abstract
effects of azacitidine on MDS outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
